What to know about Merck's acquisition of Acceleron Pharma

In this video

Share

What to know about Merck's acquisition of Acceleron Pharma

CNBC's David Faber breaks down why Merck's $11.5 billion acquisition of Acceleron Pharma could be a risky play.
05:10
Thu, Sep 30 202111:06 AM EDT